Omega Healthcare, a leading technology-enabled healthcare management solutions provider, today announced its acquisition of ApexonHealth, an AI and automation-based revenue cycle management and payor solutions provider, and Vasta Global, a provider of real-world data abstraction and analytics for the oncology market.
ApexonHealth leverages its digital solutions to deliver comprehensive technology-enabled services for both providers and payors from revenue cycle management and coding to claims management and advanced analytics. ApexonHealth’s cognitive and automation capabilities have significantly reduced manual effort and increased accuracy in claims adjudication strengthening its payor services. ApexonHealth’s expertise in the healthcare payor sector will augment Omega’s existing payor-focused offerings.
Vasta Global provides clinical data management with a focus on the oncology market and provides real-world evidence (RWE) data curation and analytics, clinical trial support, and cancer registry services for cancer centers. Vasta Global’s customers span the entire healthcare ecosystem including providers, pharmaceutical and biotechnology companies, and contract research organizations (CROs) that provide clinical trial management services.
The two acquisitions will complement Omega Healthcare’s existing strengths in revenue cycle management and clinical data management for various medical registries including cancer, stroke, and trauma. These acquisitions are part of the strategy to accelerate Omega’s journey in scaling its portfolio of AI- and data-analytics- based solutions to help healthcare clients optimize revenue while reducing cost through leveraging of big data and automation technology. With the recently completed acquisition of Reventics, Omega Healthcare will deliver an end-to-end revenue cycle management suite of solutions to healthcare providers, from analytics-driven clinical documentation improvement to platforms for payment data management. The Company will also expand its oncology-focused offering to now include big data capture and reporting to help healthcare providers and pharmaceutical companies leverage complex, longitudinal data to improve cancer treatment.
“We are pleased to welcome ApexonHealth and Vasta Global to the Omega family,” commented Anurag Mehta, CEO of Omega Healthcare. “We’ve been very impressed by the vision and execution by the two management teams. Bringing together the Omega, ApexonHealth, and Vasta offerings together will unlock significant value to our clients.”
“I am thrilled about this opportunity to join the Omega platform. Our mission to provide sustainable and scalable solutions to our clients is one that is shared by the Omega Healthcare team. With their broad capabilities, we are excited to offer our clients access to data curation, registry management, and machine learning solutions. Through this alliance, we reinforce our commitment to scientific discovery for patients through accelerated clinical research and real-world data,” said Kinjal Vora, CEO of Vasta Global.
“We are pleased to welcome ApexonHealth and Vasta Global to the Omega family,” commented Harsh Nanda, Managing Director and Head of Technology Private Equity within Goldman Sachs Asset Management. “With the acquisitions of Reventics, ApexonHealth, and Vasta Global, Omega now services more than 350 customers spanning the entire healthcare continuum with the support of robust technology-led solutions and insights. Together, we can help our clients enhance the patient experience while improving operational efficiency and strengthen our position as the partner of choice for the healthcare ecosystem.”
EY was the exclusive financial and tax advisor to ApexonHealth on the transaction.
Avendus Capital was the exclusive financial advisor to Vasta Global on this transaction.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
